Provexis plc announced the filing of a new patent application relating to the use of Fruitflow to confer health benefits in modulating the gut microbiome of humans. This follows the completion of a successful human study, the results of which (as stated in the patent application) strongly support the use of Fruitflow for modulating gut microbiota to confer a number of health benefits.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.575 GBX | -4.17% |
|
-4.17% | -11.54% |
Apr. 03 | Quiz sales fall, names new CEO; Byotrol eyes AIM exit | AN |
2023 | Provexis plc Reports Earnings Results for the Half Year Ended September 30, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-11.54% | 16.9M | |
+20.34% | 8.65B | |
-0.67% | 7.18B | |
-18.41% | 4.82B | |
-7.42% | 3.67B | |
-21.73% | 3.13B | |
-16.84% | 1.14B | |
-29.29% | 1.08B | |
-1.36% | 953M | |
-15.47% | 863M |
- Stock Market
- Equities
- PXS Stock
- News Provexis plc
- Provexis plc Announces the Filing of New Patent Application